Your browser doesn't support javascript.
loading
Leveraging Peptaibol Biosynthetic Promiscuity for Next-Generation Antiplasmodial Therapeutics.
Lee, Jin Woo; Collins, Jennifer E; Wendt, Karen L; Chakrabarti, Debopam; Cichewicz, Robert H.
Afiliação
  • Lee JW; Natural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, Oklahoma 73019, United States.
  • Collins JE; Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States.
  • Wendt KL; Natural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, Oklahoma 73019, United States.
  • Chakrabarti D; Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States.
  • Cichewicz RH; Natural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, Oklahoma 73019, United States.
J Nat Prod ; 84(2): 503-517, 2021 02 26.
Article em En | MEDLINE | ID: mdl-33565879

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trichoderma / Hypocrea / Peptaibols / Antimaláricos País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trichoderma / Hypocrea / Peptaibols / Antimaláricos País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos